Gregory Cote, M.D., Ph.D.

Physician Investigator (Cl)
Cancer Center, Mass General Research Institute
Assistant In Medicine
Medicine-Hematology/Oncology, Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
MD Boston University 2006
antibodies, monoclonal, humanized; antineoplastic agents; bone neoplasms; central nervous system neoplasms; drug resistance, multiple; endothelium, vascular; heart failure; myocytes, cardiac; nerve tissue proteins; neuregulin-1; osteosarcoma; palmitates; receptor, erbb-2; sarcoma; transplantation conditioning Dr. Cote is a medical oncologist with at the Massachusetts General Hospital Cancer Center in the Henri and Belinda Termeer Center for Targeted Therapies (Phase I), the Center for Sarcoma and Connective Tissue Oncology and the Stephan L. Harris Center for Chordoma. His primary research interest is in developing novel agents for connective tissue malignancies through translational studies and early phase clinical trials.
Publications Clinical Profile

Professional Office Building
275 Cambridge Street
Boston, MA 02114